THROMBOCYTOPENIA
Clinical trials for THROMBOCYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new THROMBOCYTOPENIA trials appear
Sign up with your email to follow new studies for THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
ITP drug study halted before it began
Disease control TerminatedThis study was designed to test an experimental drug called HMPL-523 in adults with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding problems. The goal was to see if the drug is safe and can raise platelet counts. However, th…
Matched conditions: THROMBOCYTOPENIA
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Disease control
Last updated May 17, 2026 01:47 UTC
-
Promising prostate cancer trial pulled before it even started
Disease control TerminatedThis study was withdrawn before enrolling any participants. It planned to test a radioactive drug called 177Lu-PSMA-617 in men with advanced prostate cancer that had spread to the bone marrow and caused low blood cell counts. The goal was to see if the drug was safe and could hel…
Matched conditions: THROMBOCYTOPENIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:02 UTC